Lichenoid drug eruption from ophthalmic latanoprost.
Tran JM, Falkenberry SM, Hughes SR.
Int J Dermatol. 2023 Sep;62(9):e493-e494. doi: 10.1111/ijd.16602. Epub 2023 Feb 2.
Lichenoid drug eruption induced by erenumab.
Musicante M, Goenaga-Vázquez Y, Klimas N.
JAAD Case Rep. 2022 Nov 24;32:26-28. doi: 10.1016/j.jdcr.2022.11.018. eCollection 2023 Feb.
Lichenoid Drug Eruption Induced by Teriflunomide.
Agharbi FZ, Aasfara J, Oqbani K, Slamti K, Chiheb S.
Ann Indian Acad Neurol. 2023 May-Jun;26(3):275-277. doi: 10.4103/aian.aian_27_23. Epub 2023 Jun 15.
Rifampicin-induced lichenoid drug eruption.
Bhanja DB, Sil A, Panigrahi A, Chakraborty S.
Postgrad Med J. 2020 Dec;96(1142):782-783. doi: 10.1136/postgradmedj-2019-137435. Epub 2020 Feb 3.
Lichenoid drug eruption after coronavirus disease 2019 vaccination.
Baba A, Kanekura T, Tsubouchi H.
J Dermatol. 2022 May;49(5):e159-e160. doi: 10.1111/1346-8138.16294. Epub 2021 Dec 27.
Lichenoid drug eruption associated with bisoprolol transdermal patches.
Asano A, Nakai K, Tsuruta D.
Contact Dermatitis. 2022 Feb;86(2):139-141. doi: 10.1111/cod.13995. Epub 2021 Nov 4.
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME.
J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23.
Lichenoid drug eruption on the lower lip caused by anti-PD-1 monoclonal antibody: a case report and literature review.
Kan S, Ren H, Gao Z, Dai E, Liu Y, Yang L, Cai Q.
Immunotherapy. 2021 Dec;13(17):1373-1378. doi: 10.2217/imt-2021-0234. Epub 2021 Oct 11.
Imatinib mesylate-induced lichenoid drug eruption.
Penn EH, Chung HJ, Keller M.
Cutis. 2017 Mar;99(3):189-192.
Lichenoid drug eruption.
Brauer J, Votava HJ, Meehan S, Soter NA.
Dermatol Online J. 2009 Aug 15;15(8):13.
